Selected article for: "human case and influenza virus"

Author: Klotz, Lynn C.
Title: Danger of Potential-Pandemic-Pathogen Research Enterprises
  • Document date: 2015_6_16
  • ID: 72i1x02f_14
    Snippet: If P 1 is really as low as Fouchier suggests, we would need to wait 670 years to reach a 1% chance of escape, an elapsed time that would appear to make the research enterprise safe in some researchers' thinking, but risk equals likelihood times consequences, and consequences such as fatalities could be very high for a human-contagious influenza virus with a high case fatality rate. This would lead to an intolerable number of fatalities even using.....
    Document: If P 1 is really as low as Fouchier suggests, we would need to wait 670 years to reach a 1% chance of escape, an elapsed time that would appear to make the research enterprise safe in some researchers' thinking, but risk equals likelihood times consequences, and consequences such as fatalities could be very high for a human-contagious influenza virus with a high case fatality rate. This would lead to an intolerable number of fatalities even using Fouchier's low P 1 estimate. Potential fatalities for the enterprise and the fatality burden for each lab in the enterprise were quantified for his very low P 1 of 1 Ï« 10 -6 in my published criticism (4) of Fouchier's million-year calculation. The conclusion there was that each lab in the enterprise would carry the potential burden of over 14 fatalities per year. "To put this fatality burden number in perspective, no Institutional Review Board tasked with assessing human subject research would approve a proposed research project with 14 potential fatalities per year."

    Search related documents:
    Co phrase search for related documents
    • enterprise lab and fatality burden number: 1
    • enterprise lab and fatality rate: 1
    • enterprise lab and human subject research: 1
    • enterprise lab fatality burden and fatality burden: 1
    • enterprise lab fatality burden and fatality burden number: 1
    • enterprise lab fatality burden and fatality rate: 1
    • enterprise lab fatality burden and human subject research: 1
    • fatality burden and high case: 1, 2, 3, 4
    • fatality burden and high case fatality rate: 1, 2
    • fatality burden and human subject research: 1
    • fatality burden and influenza virus: 1
    • fatality burden number and human subject research: 1
    • fatality rate and high case: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • fatality rate and high case fatality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • fatality rate and human subject research: 1
    • fatality rate and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • high case and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • high case fatality rate and influenza virus: 1, 2, 3